Evidence map›Paper›PMID 28650983›Full record

ArticlePloS one2017

Differential induction of apoptosis and autophagy by pyrrolizidine alkaloid clivorine in human hepatoma Huh-7.5 cells and its toxic implication.

Wenju Liu, Xu Li, Bo Zhou, Shoucai Fang, Wenzhe Ho, Hui Chen, Hao Liang, Li Ye, Jun Tang

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. β-Asarone improves learning and memory in AβMetabolic brain disease · 2020
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Wenju LiuKey Laboratory of Combinatorial Biosynthesis and Drug Discovery (Wuhan University), Ministry of Education, and Wuhan University School of Pharmaceutical Sciences, Wuhan, P. R. China.
Xu LiGuangxi Key Laboratory of AIDS Prevention and Treatment & Guangxi Collaborative Innovation Centre for Biomedicine, School of Public Health, Guangxi Medical University, Nanning City, Guangxi, P. R. China.
Bo ZhouGuangxi Key Laboratory of AIDS Prevention and Treatment & Guangxi Collaborative Innovation Centre for Biomedicine, School of Public Health, Guangxi Medical University, Nanning City, Guangxi, P. R. China.
Shoucai FangGuangxi Key Laboratory of AIDS Prevention and Treatment & Guangxi Collaborative Innovation Centre for Biomedicine, School of Public Health, Guangxi Medical University, Nanning City, Guangxi, P. R. China.
Wenzhe HoDepartment of Pathology and Laboratory Medicine, Temple University School of Medicine, Philadelphia, PA, United States of America.
Hui ChenGeriatrics Digestion Department of Internal Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning City, Guangxi, P. R. China.
Hao LiangGuangxi Key Laboratory of AIDS Prevention and Treatment & Guangxi Collaborative Innovation Centre for Biomedicine, School of Public Health, Guangxi Medical University, Nanning City, Guangxi, P. R. China.
Li YeGuangxi Key Laboratory of AIDS Prevention and Treatment & Guangxi Collaborative Innovation Centre for Biomedicine, School of Public Health, Guangxi Medical University, Nanning City, Guangxi, P. R. China.
Jun TangKey Laboratory of Combinatorial Biosynthesis and Drug Discovery (Wuhan University), Ministry of Education, and Wuhan University School of Pharmaceutical Sciences, Wuhan, P. R. China.
Guangxi Medical University · CNWuhan University · CNFirst Affiliated Hospital of GuangXi Medical University · CNTemple University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Growing evidence suggests that the pyrrolizidine alkaloids (PAs)-induced hepatotoxicity is mediated by multiple cell death/defence modalities. However, the detailed mechanisms are still lacking. In this study, the hepatotoxic effects of four PAs including three retronecine-type ones (senecionine, seneciphylline and monocrotaline) and one otonecine-type (clivorine) on the proliferation of Huh-7.5 cells and the possible mechanisms were investigated. The results showed that all the PAs could inhibit cell proliferation and induce apoptosis in a concentration-dependent manner. Among them clivorine was the most significant one. In addition to its effect on apoptosis, clivorine treatment could promote autophagy in Huh-7.5 cells, as evidenced by the accumulation of autophagosomes, the enhancement of LC3B expression at the concentrations close to its IC0 value, and the increased conversion of LC3B-I to LC3B-II in the presence of lysosomal inhibitor (chloroquine) and decreased formation of green fluorescent protein (GFP)-LC3 positive puncta in the presence of autophagic sequestration inhibitor (3-methyladenine). Among the other tested PAs, senecionine and seneciphylline also activated autophagy at the same concentrations used for clivorine but monocrotaline did not. Furthermore, our study demonstrated that suppression or enhancement of autophagy resulted in the remarkable enhancement or suppression of senecionine, seneciphylline and clivorine-induced apoptosis at the concentration close to the IC10 for clivorine, respectively, indicating a protective role of autophagy against the PA-induced apoptosis at the low level of exposure. Collectively, our data suggest that PAs in different structures may exert different toxic disturbances on the liver cells. Apoptosis may be one of the most common models of the PA-induced cytotoxicity, while autophagy may be a structure-dependent defence model in the early stage of PA intoxication. Differential induction of apoptosis and autophagy probably depending on the concentration is essential for the cytotoxic potency of clivorine.

Indexed as

ApoptosisAutophagyCarcinoma, HepatocellularCell Line, TumorHepatocytesHumansLiver NeoplasmsPhagosomesPyrrolizidine AlkaloidsclivorinePyrrolizidine Alkaloids

Identifiers

PMID28650983
PMCPMC5484491
OpenAlexW2704816799

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.